Cargando…

Super high-flux CVVHD using regional citrate anticoagulation: long-term stability of middle molecule clearance

Detalles Bibliográficos
Autores principales:	Siebeck, M, Kindgen-Milles, D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471236/ http://dx.doi.org/10.1186/cc14381

Ejemplares similares

Multicenter prospective observational study on safety and efficacy of regional citrate anticoagulation in CVVHD in the presence of liver failure: the Liver Citrate Anticoagulation Threshold Study (L-CAT)
por: Slowinski, T, et al.
Publicado: (2011)

Regional citrate anticoagulation in high-volume continuous venovenous hemodialysis
por: Kalb, R, et al.
Publicado: (2011)

Citrate anticoagulation realized as CVVHD using a newly designed dialysate solution
por: Morgera, S, et al.
Publicado: (2006)

Dialyzer clearance of myoglobin with middle molecule filter and low blood flow CVVHD in patients with rhabdomyolysis-associated acute kidney injury
por: Leppanen, I, et al.
Publicado: (2013)

Thrombin Generation and Platelet Function in ICU Patients Undergoing CVVHD Using Regional Citrate Anticoagulation
por: Wiegele, Marion, et al.
Publicado: (2021)

Blood epuration of middle molecules in continuous venovenous hemodiafiltration with regional citrate anticoagulation versus systemic heparinization
por: Nogier, MB, et al.
Publicado: (2009)

Elimination rates of electrolytes, vitamins and trace elements during continuous renal replacement therapy with citrate CVVHD: influence of treatment dose
por: Von Freyberg, P, et al.
Publicado: (2014)

Ionized calcium measurements during regional citrate anticoagulation in CRRT: we need better blood gas analyzers
por: Kindgen-Milles, Detlef, et al.
Publicado: (2015)

The pharmacokinetics of tigecycline in critically ill adult patients undergoing CVVHD
por: Rypulak, E, et al.
Publicado: (2015)

Regional citrate anticoagulation in CVVH: a new protocol combining citrate solution with a phosphate-containing replacement fluid
por: Morabito, S, et al.
Publicado: (2012)

Regional citrate anticoagulation with a low-concentration solution in predilution-postdilution CVVH
por: Pistolesi, V, et al.
Publicado: (2012)

Blood transfusion requirements and filter longevity with regional citrate anticoagulation compared with heparin
por: Burford, E, et al.
Publicado: (2015)

Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study
por: Slowinski, Torsten, et al.
Publicado: (2015)

Stability of citrate and calcium dosing in citrate renal replacement therapy
por: Sadaat, F, et al.
Publicado: (2015)

Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation
por: Kozik-Jaromin, Justyna, et al.
Publicado: (2009)

Pilot study on a regional citrate anticoagulated continuous venovenous hemodiafiltration protocol with variable treatment dose
por: Slowinski, T, et al.
Publicado: (2010)

Effects of two different regional citrate anticoagulation CVVH protocols on acid-base status and phosphate supplementation
por: Morabito, S, et al.
Publicado: (2013)

Middle molecule clearance with high cut-off dialyzer versus high-flux dialyzer using continuous veno-venous hemodialysis with regional citrate anticoagulation: A prospective randomized controlled trial
por: Weidhase, Lorenz, et al.
Publicado: (2019)

Impact of continuous veno-venous hemodiafiltration with regional citrate anticoagulation on the acid-base balance of critically ill patients
por: Passos, RH, et al.
Publicado: (2006)

Continuous renal replacement therapy (CVVHD) for acute kidney injury in critical care: incidence and outcome across South West Wales
por: Brown, K, et al.
Publicado: (2014)

Dynamics of the dosage of citrate-calciuminfusion regimens as anticoagulation in continuous venovenous hemodiafiltration
por: Marin Mateos, H, et al.
Publicado: (2015)

Citrate anticoagulation for continuous venovenous haemodiafiltration: the impact of a novel protocol on patients receiving therapy in one regional hospital
por: Highgate, J, et al.
Publicado: (2015)

Comparison of the efficacy and safety of two regional citrate anticoagulation protocols using acid citrate dextrose A or Prismocitrate 10/2, in patients with acute renal failure undergoing continuous venovenous haemodiafiltration
por: Ooi, EL, et al.
Publicado: (2010)

Variable adsorption of insulin at catheter materials used in intensive care units: polyethylene vs polyurethane – possible cause for hypoglycemia during intensive insulin treatment?
por: Ley, S, et al.
Publicado: (2007)

Simple citrate anticoagulation protocol for low flux haemodialysis
por: Lim, Eng Kuang, et al.
Publicado: (2018)

Citrate anticoagulation protocol to treat septic shock patients with liver dysfunction in CPFA extracorporeal therapy
por: Ferrari, F, et al.
Publicado: (2012)

Recurrent early filter clotting in regional citrate anticoagulated continuous venovenous hemodialysis due to undetected antibodies to heparin-platelet factor 4 complexes
por: Slowinski, T, et al.
Publicado: (2010)

Preventing continuous renal replacement therapies (CRRT)-induced hypophosphatemia using a phosphate-containing CRRT solution in the setting of regional citrate anticoagulation
por: Pistolesi, V, et al.
Publicado: (2014)

Super high-flux continuous hemodialysis: an efficient compromise for blood purification in sepsis
por: Rimmelé, T, et al.
Publicado: (2012)

Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill patients with acute kidney injury (RICH) trial: study protocol for a multicentre, randomised controlled trial
por: Meersch, Melanie, et al.
Publicado: (2019)

Combined use of pumpless extracorporeal lung assist system and continuous renal replacement therapy with citrate anticoagulation in polytrauma patients
por: Atalan, HK, et al.
Publicado: (2013)

Impact of CVVHD on pulmonary gas exchange measurement
por: Srámek, V, et al.
Publicado: (1997)

Regional citrate anticoagulation “non-shock” protocol with pre-calculated flow settings for patients with at least 6 L/hour liver citrate clearance
por: Yessayan, Lenar, et al.
Publicado: (2021)

Comparison of pre-filter and post-filter ionised calcium monitoring in continuous veno-venous hemodiafiltration (CVVHD-F) with citrate anti-coagulation
por: Brain, Matthew J., et al.
Publicado: (2017)

Economic argument for citrate haemofiltration
por: Patterson, J, et al.
Publicado: (2011)

Ion-exchange resin anticoagulation: experimental data of a novel extracorporeal regional anticoagulation technique
por: Zanella, A, et al.
Publicado: (2015)

Complications of regional citrate anticoagulation: accumulation or overload?
por: Schneider, Antoine G., et al.
Publicado: (2017)

Regional Citrate Anticoagulation for Intermittent Hemodialysis in Dogs
por: Francey, T., et al.
Publicado: (2017)

Middle molecules in severe community-acquired pneumonia
por: Dumitras, T, et al.
Publicado: (2015)

Impact of anion exchange adsorbents on regional citrate anticoagulation
por: Strobl, Karin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_snn1ep0qee7vf6brkf9gir780e